RBC Capital analyst Michael Carroll reiterated a Hold rating on MedEquities Realty Trust (MRT) yesterday and set a price target of $9. The company’s shares opened today at $7.27, equals to its 52-week low of $7.27.
According to TipRanks.com, Carroll is a 4-star analyst with an average return of 9.7% and a 78.7% success rate. Carroll covers the Financial sector, focusing on stocks such as Government Properties Income Trust, Easterly Government Properties, and Americold Realty Trust.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for MedEquities Realty Trust with a $10.30 average price target, implying a 41.7% upside from current levels. In a report issued on November 12, Citigroup also upgraded the stock to Hold with a $9 price target.
.
See today’s analyst top recommended stocks >>
MedEquities Realty Trust’s market cap is currently $236.4M and has a P/E ratio of 20.01. The company has a Price to Book ratio of 0.68.
Based on the recent corporate insider activity of 43 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MedEquities Realty Trust, Inc. operates as a real estate investment trust. It focuses on investment in healthcare properties and healthcare related real estate debt investments. It owns, develops, operates, leases, and disposes healthcare properties and portfolios. The company was founded in April 23, 2014 and is headquartered in Nashville, TN.
